Stamford Health
Stamford Health

A real-world chronic myelogenous leukemia (CML) patient disease registry

Back to Results

A real-world chronic myelogenous leukemia (CML) patient disease registry

Novartis CABL001J1US01 (ASC4REAL-2) – A real-world chronic myelogenous leukemia (CML) patient disease registry to describe patient experience and clinical outcomes among patients with CML receiving approved first or second line tyrosine kinase inhibitor (TKI) therapy (NCT07091019)

Principal Investigator(s)

Joshua R. Dower, MD

Location

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.

ACCEPT AND CLOSE